Literature DB >> 10773016

Coexpression of full-length gamma-aminobutyric acid(B) (GABA(B)) receptors with truncated receptors and metabotropic glutamate receptor 4 supports the GABA(B) heterodimer as the functional receptor.

R Sullivan1, A Chateauneuf, N Coulombe, L F Kolakowski, M P Johnson, T E Hebert, N Ethier, M Belley, K Metters, M Abramovitz, G P O'Neill, G Y Ng.   

Abstract

Direct evidence is lacking to show whether the gamma-aminobutyric acid (GABA)(B) gb1-gb2 heterodimer is the signaling form of the receptor. In this study, we tested whether gb1a or gb2 subunits when coexpressed with truncated receptors or metabotropic glutamate receptor mGluR4 could form functional GABA receptors. Coexpression of the ligand binding N-terminal domain of gb1a or the C-terminal portion of gb1a composing the seven-transmembrane segments and intracellular loops with gb2 could not reconstitute functional receptors. We next examined whether mGluR4, which forms homodimers and is structurally related to GABA(B), could act as a surrogate coreceptor for gb1 or gb2. The coexpression of mGluR4 and gb1a led to the expression of gb1a monomers on cell surface membranes as determined by immunoblot analysis and flow cytometry. However, mGluR4-gb1a heterodimers were not formed, and membrane-expressed gb1a monomers were not functionally coupled to adenylyl cyclase in human embryonic kidney 293 cells or activated inwardly rectifying potassium (Kir) channels in Xenopus oocytes. Similarly, the coexpression of mGluR4 and gb2 led to nonfunctional GABA receptors. GABA-activated distal signaling events resulted only after the coexpression and heterodimerization of gb1 and gb2. Taken together with the truncated receptor studies, the data suggest that a high degree of structural specificity is required to form the functional GABA(B) receptor that is a gb1-gb2 heterodimer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10773016

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  The C-terminal domains of the GABA(b) receptor subunits mediate intracellular trafficking but are not required for receptor signaling.

Authors:  A R Calver; M J Robbins; C Cosio; S Q Rice; A J Babbs; W D Hirst; I Boyfield; M D Wood; R B Russell; G W Price; A Couve; S J Moss; M N Pangalos
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

2.  C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABA(b) receptors.

Authors:  A Pagano; G Rovelli; J Mosbacher; T Lohmann; B Duthey; D Stauffer; D Ristig; V Schuler; I Meigel; C Lampert; T Stein; L Prezeau; J Blahos; J Pin; W Froestl; R Kuhn; J Heid; K Kaupmann; B Bettler
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

3.  Positive regulation by γ-aminobutyric acid B receptor subunit-1 of chondrogenesis through acceleration of nuclear translocation of activating transcription factor-4.

Authors:  Yoshifumi Takahata; Eiichi Hinoi; Takeshi Takarada; Yukari Nakamura; Shinya Ogawa; Yukio Yoneda
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

4.  Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation.

Authors:  B A Jordan; N Trapaidze; I Gomes; R Nivarthi; L A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

5.  Sleep-deprivation induces changes in GABA(B) and mGlu receptor expression and has consequences for synaptic long-term depression.

Authors:  Ramakrishna Tadavarty; Padmesh S Rajput; Jennifer M Wong; Ujendra Kumar; Bhagavatula R Sastry
Journal:  PLoS One       Date:  2011-09-27       Impact factor: 3.240

6.  Positive regulation by GABA(B)R1 subunit of leptin expression through gene transactivation in adipocytes.

Authors:  Yukari Nakamura; Eiichi Hinoi; Takeshi Takarada; Yoshifumi Takahata; Tomomi Yamamoto; Hiroyuki Fujita; Saya Takada; Syota Hashizume; Yukio Yoneda
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.